The US government has now invested nearly $6 billion in an effort led by President Biden to provide a lifeline to Moderna amid the COVID-19 crisis.
Those analyzing the COVID-19 crisis and its effects have mostly focused on how its disruptive nature has led to major shifts and recalibrations throughout society and the economy. Such disruption has also lent itself to a variety of agendas that had required an event of “reset” potential in order to be realized. In the case of the vaccine industr...
